Progress of Cancer Precision Medical by Approval of Medical Insurance of Cancer Gene Panel Test
Journal Title: International Journal of Trend in Scientific Research and Development - Year 2020, Vol 4, Issue 2
Abstract
Public medical insurance is applied to the genetic testing system of Cancer genomic medicine , which chooses the most appropriate drug from the result of examining the gene mutation of the patients cancer cell. The curtain of cancer genomic medicine era was opened. Healthcare professionals want to understand the possibilities and limitations of testing and to steadily develop this medical technology. The testing equipment are the OncoGuide™ NCC oncopanel system developed by the National Cancer Research Center and the Foundation One CDx produced by Chugai Pharmaceutical Company. In each case, more than 100 types of cancer related gene mutations can be examined at one time. The number of patients eligible for genome medical treatment is estimated to be approximately 26,000 for patients with solid and rare cancers without standard treatment. Until now, it cost several hundred thousand yen for the patient. Patients who are said to have no cure are tested to a small degree, are looking for anti cancer drugs that could be used. With public health insurance, a series of tests cost 560,000 yen, for people under the age of 70 with average income, medical expenses are about 80,000 yen. It will be able to receive examinations widely at less than 200 medical institutions nationwide. This new cancer treatment gives new hope to patients with cancer. However, patients with cancer should not have excessive expectations. It is necessary to keep in mind that there is a limit to clinical cancer treatment. Takuma Hayashi | Takashi Ura | Ikuo Konishi ""Progress of Cancer Precision Medical by Approval of Medical Insurance of Cancer Gene Panel Test"" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-2 , February 2020, URL: https://www.ijtsrd.com/papers/ijtsrd29914.pdf Paper Url : https://www.ijtsrd.com/medicine/other/29914/progress-of-cancer-precision-medical-by-approval-of-medical-insurance-of-cancer-gene-panel-test/takuma-hayashi
Authors and Affiliations
Takuma Hayashi | Takashi Ura | Ikuo Konishi
Keywords
Related Articles
- EP ID EP685878
- DOI -
- Views 101
- Downloads 0
Flotation Results of Oxidized Copper Ores of the Kalmakyr Deposit
According to preliminary calculations, oxidized copper ores in the dumps of the Kalmakyr deposit are about 107.6 million tons 01.01.2020 of which Balance ores 12.1 million tons with a Cu content of 0.8 Au 1.2 g t Ag 3.9...
A Study on Ad Hoc on Demand Distance Vector AODV Protocol
AODV is a very simple, efficient, and effective routing protocol for Mobile Ad hoc Net works which do not have fixed topology. This algorithm was motivated by the limited bandwidth that is available in the media that are...
Anti Inflammatory Activity of Ormosia Calavensis Azola Bahai Leaf Extract
This study determined the anti inflammatory activity of Ormosia calavensis azola Bahai leaf extract. The physical properties test shows that the plant extract is acidic, less dense in water and polar. The alkaloids, flav...
A CFD Study on Plate Heat Exchanger using Nanofluid with Different Corrugated Channels Configurations under Forced Convection Flow
Notwithstanding the fact that various empirical experiments have been performed on heat transfer and pressure drop in the corrugated surface as a result of parametric variance of the individual surface pattern. Nonethele...
Virtual Therapist for Psychological Healthcare
Nowadays Stress has been a quite common ailment in people. We believe that when technology is used to build understanding, it can help humanity in creative and effective ways. That idea lives at the core of our paper in...